Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew C Perez

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Hematology/Oncology Clinics of North America|November 12, 2025
Management of In-Transit Metastatic MelanomaMatthew C Perez, Jonathan S Zager
Annals of Surgical Oncology|August 29, 2018
ASO Author Reflections: Resection Margins in Merkel Cell Carcinoma: Is a 1 cm Margin Wide Enough?Matthew C Perez, Jonathan S Zager
Expert Opinion on Drug Safety|August 8, 2023
A safety review of recently approved and late-stage trial treatments for metastatic melanoma: systemic and regional therapiesMatthew C Perez, Danielle K Depalo, Jonathan S Zager
Cancers|July 13, 2024
Clinical Characteristics and Special Considerations in the Management of Rare Melanoma SubtypesAdrienne B Shannon, Jonathan S Zager, Matthew C Perez
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|September 13, 2017
Current standards of surgical management in primary melanomaMatthew C Perez, Sonia T Orcutt, Jonathan S Zager
BMJ Case Reports|August 16, 2018
Severe thromboembolic phenomenon in the setting of pseudoprogression of melanoma brain metastases in response to combination immunotherapyMatthew C Perez, Hsiang-Hsuan M Yu, Joseph Markowitz
Cancer Management and Research|August 5, 2024
Combination Atezolizumab, Cobimetinib, and Vemurafenib as a Treatment Option in BRAF V600 Mutation-Positive Melanoma: Patient Selection and PerspectivesMichelle M Dugan, Matthew C Perez, Lilit Karapetyan, et al.
Frontiers in Oncology|February 23, 2024
Management of acral lentiginous melanoma: current updates and future directionsMichelle M Dugan, Matthew C Perez, Lilit Karapetyan, et al.
JAMA Network Open|December 2, 2024
Smartphone App-Based Contingency Management and Opioid Use Disorder Treatment OutcomesElise N Marino, Tara Karns-Wright, Matthew C Perez, et al.
Clinical & Experimental Metastasis|October 16, 2023
Isolated hyperthermic perfusions for cutaneous melanoma in-transit metastasis of the limb and uveal melanoma metastasis to the liverAnne Huibers, Danielle K DePalo, Matthew C Perez, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Hematology/Oncology Clinics of North America|November 12, 2025
Management of In-Transit Metastatic MelanomaMatthew C Perez, Jonathan S Zager
Annals of Surgical Oncology|August 29, 2018
ASO Author Reflections: Resection Margins in Merkel Cell Carcinoma: Is a 1 cm Margin Wide Enough?Matthew C Perez, Jonathan S Zager
Expert Opinion on Drug Safety|August 8, 2023
A safety review of recently approved and late-stage trial treatments for metastatic melanoma: systemic and regional therapiesMatthew C Perez, Danielle K Depalo, Jonathan S Zager
Cancers|July 13, 2024
Clinical Characteristics and Special Considerations in the Management of Rare Melanoma SubtypesAdrienne B Shannon, Jonathan S Zager, Matthew C Perez
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|September 13, 2017
Current standards of surgical management in primary melanomaMatthew C Perez, Sonia T Orcutt, Jonathan S Zager
BMJ Case Reports|August 16, 2018
Severe thromboembolic phenomenon in the setting of pseudoprogression of melanoma brain metastases in response to combination immunotherapyMatthew C Perez, Hsiang-Hsuan M Yu, Joseph Markowitz
Cancer Management and Research|August 5, 2024
Combination Atezolizumab, Cobimetinib, and Vemurafenib as a Treatment Option in BRAF V600 Mutation-Positive Melanoma: Patient Selection and PerspectivesMichelle M Dugan, Matthew C Perez, Lilit Karapetyan, et al.
Frontiers in Oncology|February 23, 2024
Management of acral lentiginous melanoma: current updates and future directionsMichelle M Dugan, Matthew C Perez, Lilit Karapetyan, et al.
JAMA Network Open|December 2, 2024
Smartphone App-Based Contingency Management and Opioid Use Disorder Treatment OutcomesElise N Marino, Tara Karns-Wright, Matthew C Perez, et al.
Clinical & Experimental Metastasis|October 16, 2023
Isolated hyperthermic perfusions for cutaneous melanoma in-transit metastasis of the limb and uveal melanoma metastasis to the liverAnne Huibers, Danielle K DePalo, Matthew C Perez, et al.
Pageof 4